Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours(678 views) Ramundo V, Del Prete M, Marotta V, Marciello F, Camera L, Napolitano V, de LucaL, Circelli L, Colantuoni V, Di Sarno A, Carratu AC, Di Roseto CDL, Colao A, Faggiano A
Department of Clinical Medicine and Surgery, Federico II University of Naples, Via S. Pansini 5, 80131 Napoli, Italy
Biomorphologic and Functional Sciences, Federico II University of Naples, Naples, Italy
Internal Medicine, Second University of Naples, Naples, Italy
Gastroenterology and Digestive Endoscopy, Pellegrini Hospital, Naples ASL NA1, Italy
Oncological Immunology, Istituto Nazionale Tumori Fondazione G.Pascale - IRCCS, Naples, Italy
Biological Geological and Environmental Sciences, University of Sannio, Benevento, Italy
Interventional Unit, Azienda Dei Colli Hospital, Naples, Italy
Endocrinology, Istituto Nazionale Tumori Fondazione G.Pascale - IRCCS, Naples, Italy
References: Not available.
Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours